Showing results (131-140 of 302) with videos related to

Sort By:
Pageof 31
Antimicrobial Agents and Chemotherapy|June 5, 2019
Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant RecipientsAurélie Velay, Morgane Solis, Ilies Benotmane, et al.
Transplantation Proceedings|February 10, 2021
Hemodynamic Management During Kidney Transplantation: A French SurveyOlivier Collange, Charles Tacquard, Walid Oulehri, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2010
The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary reportLeon J Schurgers, Daniela V Barreto, Fellype C Barreto, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|July 27, 2018
Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney DiseaseLaurent Puy, Jean-Marc Bugnicourt, Sophie Liabeuf, et al.
Journal of Internal Medicine|April 25, 2022
Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to actionPatrice Cacoub, Gabriel Choukroun, Alain Cohen-Solal, et al.
Nutrients|March 10, 2022
Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory DiseasesPatrice Cacoub, Gabriel Choukroun, Alain Cohen-Solal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2007
Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantationMatthieu Monge, Nelly Ledemé, Hakim Mazouz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2009
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney diseaseSophie Liabeuf, Daniela V Barreto, Fellype C Barreto, et al.
Pageof 31